


















![]()
Devyser Diagnostics AB (publ) (DVYSF) Q1 2026 Earnings Call April 27, 2026 5:00 AM EDT
Company Participants
Jan Wahlstrom - Chief Executive Officer
Sabina Berlin - Chief Financial Officer
Conference Call Participants
Ulrik Trattner - DNB Carnegie, Research Division
Filip Wiberg - Pareto Securities AS, Research Division
Ludvig Lundgren - Nordea Markets, Research Division
Presentation
Operator
Welcome to Devyser Diagnostics Q1 Report 2026 presentation. [Operator Instructions] Now I will hand the conference over to the speakers. CEO, Jan Wahlstrom; and CFO, Sabina Berlin. Please go ahead.
Jan Wahlstrom
Chief Executive Officer
Good morning, and welcome to the Devyser Q1 2026 Earnings Call. My name is Jan Wahlstrom. I'm the CEO of Devyser and would like to thank you, everyone, for joining our call today. On the call today, we have, in addition to myself, also our CFO, Sabina Berlin. I will start with a short summary of highlights from the quarter before handing over to Sabina for a more detailed review of our financial results for January to March, and then we'll go through an update on our recent commercial activities.
First quarter came in with a positive EBIT, the fourth consecutive quarter in a row. As you know, we started the journey in the beginning of last year, focusing the company towards profitable growth. It's been a successful journey, and we're happy to deliver a strong growth and positive EBIT. In the first quarter of the year, we continue to grow faster than the market. We grew 24% in fixed currencies. We received quite a few orders from Thermo in this quarter, a step towards a more stable order pattern.
We're also very pleased with the gross margin of 82%. It's better than full year 2025, and we will continue to work on improving cost of goods sold. EBIT came in on a
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。